Cargando…
From CGRP to PACAP, VIP, and Beyond: Unraveling the Next Chapters in Migraine Treatment
Migraine is a neurovascular disorder that can be debilitating for individuals and society. Current research focuses on finding effective analgesics and management strategies for migraines by targeting specific receptors and neuropeptides. Nonetheless, newly approved calcitonin gene-related peptide (...
Autores principales: | Tanaka, Masaru, Szabó, Ágnes, Körtési, Tamás, Szok, Délia, Tajti, János, Vécsei, László |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670698/ https://www.ncbi.nlm.nih.gov/pubmed/37998384 http://dx.doi.org/10.3390/cells12222649 |
Ejemplares similares
-
Release of PACAP-38 in episodic cluster headache patients – an exploratory study
por: Tuka, Bernadett, et al.
Publicado: (2016) -
Exploring Novel Therapeutic Targets in the Common Pathogenic Factors in Migraine and Neuropathic Pain
por: Tajti, János, et al.
Publicado: (2023) -
Treatment of Chronic Migraine with OnabotulinumtoxinA: Mode of Action, Efficacy and Safety
por: Szok, Délia, et al.
Publicado: (2015) -
Chronic Migraine as a Primary Chronic Pain Syndrome and Recommended Prophylactic Therapeutic Options: A Literature Review
por: Szok, Délia, et al.
Publicado: (2023) -
The effect of orofacial complete Freund’s adjuvant treatment on the expression of migraine-related molecules
por: Körtési, Tamás, et al.
Publicado: (2019)